Jongkundang recently announced on the 13th that it has launched the health functional food ‘Joint Health Project 365 Boswellia 7 Days’. This product is an individually recognized health functional food with 'Serratrin,' a Boswellia extract recognized by the Ministry of Food and Drug Safety for joint and cartilage health functionality, as its main ingredient.

Jongkundang's 'Joint Health Project 365 Boswellia 7 Days' <br>[Photo by Jongkundang]

Jongkundang's 'Joint Health Project 365 Boswellia 7 Days'
[Photo by Jongkundang]

View original image

Jongkundang explained that to increase the absorption rate of six types of boswellic acids that help joint and cartilage health, they used a triple extraction method that neutralizes by blending non-acidic components, securing 100% pure Boswellia extract, which was then concentrated 600% and its functionality proven through human application tests. Boswellia is a tree with strong vitality that grows in harsh climates of high-altitude areas such as East Africa and India. However, only about 400 to 500 grams of extract can be harvested from one tree over two years.


In addition to the main ingredient, this product contains four types of vitamin B complex and zinc and selenium necessary for energy production, and is formulated to meet 100% of the daily nutritional intake standards considering normal immune function and antioxidant effects. It is an all-in-one product that fulfills various functionalities such as joint and cartilage health, immunity, and antioxidation with just one tablet a day.



A representative from Jongkundang said, “In winter, muscles tense up and joint functions decline, making it easy to get injured during exercise with muscle and ligament tears or fractures, so consistent management is necessary.” He added, “The Joint Health Project 365 Boswellia 7 Days, whose functionality has been proven, will help manage joint and cartilage health.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing